Clinical and Virological Outcome of Monoclonal Antibody Therapies Across SARS-CoV-2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study

Sammy Huygens(Ghent University Hospital), Bas B. Oude Munnink(University of Amsterdam), Arvind Gharbharan(Erasmus MC), Susanne Bogers(Erasmus MC), Corine H. GeurtsvanKessel(Pulmonary Associates), Linda M. Kampschreur(Medisch Centrum Leeuwarden), Hannelore I. Bax(Erasmus MC), Henriëtte Levenga(Groene Hart Ziekenhuis), Bart Rijnders(Rega Institute for Medical Research), Roel B. Fiets(Amphia Ziekenhuis), Marjan Boter(Erasmus MC), Pedro Miranda Afonso(Erasmus MC), Marion Koopmans(National Institute for Public Health and the Environment), Robert‐Jan Hassing(Rijnstate Hospital), Nathalie Worp(Universitat Pompeu Fabra)
Clinical Infectious Diseases
March 6, 2024
Cited by 15


Related Papers